CymaBay Therapeutics (CBAY) – Hot Corp. News
-
Gilead Sciences (GILD) to Acquire CymaBay Therapeutics (CBAY) for $32.50 Per Share, $4.3 Billion
-
CymaBay Therapeutics (CBAY) Announces FDA Lifts All Clinical Holds on Seladelpar
-
-
-
-
-
-
-
-
-
-
Back to CBAY Stock Lookup